Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Abstract

In patients with invasive aspergillosis, initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B.